Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Erika Longhi"'
Autor:
Verena Habermaass, Daniela Olivero, Eleonora Gori, Chiara Mariti, Erika Longhi, Veronica Marchetti
Publikováno v:
Animals, Vol 13, Iss 20, p 3174 (2023)
The gut–liver axis represents a current topic in human medicine. Extensive research investigates the gut microbiome (GM) modifications in relation to various kinds of chronic hepatobiliary diseases (CHD), with many mechanisms and therapeutical impl
Externí odkaz:
https://doaj.org/article/b78b9eb8536d4fe1918d35ef088f5c65
Autor:
Sara G. Rimoldi, Cristina Pagani, Erika Longhi, Valentina D. Cristo, Annamaria D. Gregorio, Alessandro Mancon, Pietro Zerbi, Cristina Gervasoni, Maria R. Gismondo, Agostino Riva
Publikováno v:
Journal of Infection and Public Health, Vol 11, Iss 2, Pp 255-259 (2018)
One of the most important Staphylococcus aureus virulence factors is Panton–Valentine leukocidin (PVL). We describe an outbreak of recurrent cutaneous PVL infections in different members of three family clusters. Molecular investigations were perfo
Externí odkaz:
https://doaj.org/article/25662a8639e749e19e907e92e414a842
Autor:
Elena Dozio, Elena Vianello, Francesco Bandera, Erika Longhi, Stefano Brizzola, Manuela Nebuloni, Massimiliano M. Corsi Romanelli
Publikováno v:
Mediators of Inflammation, Vol 2019 (2019)
Most of the obesity-related complications are due to ectopic fat accumulation. Recently, the activation of the cell-surface receptor for advanced glycation end products (RAGE) has been associated with lipid accumulation in different organs. Neverthel
Externí odkaz:
https://doaj.org/article/d955549f03b84cf2b05d8245f2a88ce4
Autor:
Spinello Antinori, Oleg Mediannikov, Mario Corbellino, Romualdo Grande, Carlo Parravicini, Giovanna Bestetti, Erika Longhi, Davide Ricaboni, Cyrille Bilé Ehounoud, Florence Fenollar, Didier Raoult, Sara Giordana Rimoldi
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 10, Iss 5, p e0004522 (2016)
Externí odkaz:
https://doaj.org/article/261a914e9f154082b60877edd81127db
Autor:
Raffaele Allevi, Beatrice Marchini, Gianluca M. Sampietro, Fabio Corsi, Pietro Zerbi, Marta Sevieri, Lucia Morelli, Francesco Colombo, Matteo Monieri, Arianna Bonizzi, Erika Longhi, Marta Truffi, Miriam Colombo, Davide Prosperi, Luca Sorrentino, Serena Mazzucchelli
Publikováno v:
International Journal of Nanomedicine. 15:8537-8552
Purpose Assessment of inflammatory bowel disease (IBD) currently relies on aspecific clinical signs of bowel inflammation. Specific imaging of the diseased bowel regions is still lacking. Here, we investigate mucosal addressin cell adhesion molecule
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6983fe64caae528723859d41cbccb758
https://doi.org/10.2147/ijn.s264513
https://doi.org/10.2147/ijn.s264513
Autor:
Elena Dozio, Elena Vianello, Marco Guazzi, Erika Longhi, Lorenza Tacchini, Gerd Schmitz, Manuela Nebuloni, Francesco Bandera, Massimiliano Marco Corsi Romanelli
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-3 (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aa69744f078e6abf1d37bb5443a18f1
http://link.springer.com/article/10.1038/s41598-020-58143-y
http://link.springer.com/article/10.1038/s41598-020-58143-y
Autor:
Fabio Corsi, Erika Longhi, Davide Prosperi, Marta Truffi, Michela Bellini, Serena Mazzucchelli, Matteo Monieri, Luca Sorrentino, Pietro Zerbi, R Ottria, Arianna Bonizzi, F. Andreata
Publikováno v:
Cancer Research. 79:P1-20
Background: HER2+ breast cancer (BC) accounts for 20-25 % of BCs and it is characterized by high aggressiveness.1 Despite the anti-HER2 monoclonal antibody Trastuzumab (TZ) has improved BC clinical outcome, it could induce severe cardiac reversible d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fac4d21ede6d84b066dddabf9f54a62e
https://doi.org/10.1158/1538-7445.sabcs18-p1-20-04
https://doi.org/10.1158/1538-7445.sabcs18-p1-20-04
Autor:
Erika Longhi, Annamaria Di Gregorio, Cristina Pagani, Alessandro Mancon, Agostino Riva, Valentina Di Cristo, Pietro Zerbi, Sara Giordana Rimoldi, Maria Rita Gismondo, Cristina Gervasoni
Publikováno v:
Journal of Infection and Public Health, Vol 11, Iss 2, Pp 255-259 (2018)
One of the most important Staphylococcus aureus virulence factors is Panton–Valentine leukocidin (PVL). We describe an outbreak of recurrent cutaneous PVL infections in different members of three family clusters. Molecular investigations were perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::465bd95f08f958974ce6aa10aaa01775
https://doi.org/10.1016/j.jiph.2017.08.012
https://doi.org/10.1016/j.jiph.2017.08.012
Autor:
Davide Prosperi, Erika Longhi, Marta Truffi, L. Fiandra, Luca Sorrentino, Serena Mazzucchelli, Michela Bellini, F.M.R. Corsi, Manuela Nebuloni, Maria Antonietta Rizzuto
Publikováno v:
Cancer Research. 77:P6-12
Chemotherapeutic treatment of breast cancer is based on maximum tolerated dose (MTD) approach.1 However, advanced stage tumors are not effectively eradicated by MTD owing to suboptimal drug targeting, onset of therapeutic resistance and neoangiogenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fd6faa363acd94a84958d39000cbeff
https://doi.org/10.1158/1538-7445.sabcs16-p6-12-17
https://doi.org/10.1158/1538-7445.sabcs16-p6-12-17
Autor:
Luca Sorrentino, Fabio Corsi, Luisa Fiandra, Serena Mazzucchelli, Davide Prosperi, Manuela Nebuloni, Michela Bellini, Maria Antonietta Rizzuto, Marta Truffi, Erika Longhi
Publikováno v:
Oncotarget
// Serena Mazzucchelli 1 , Michela Bellini 2 , Luisa Fiandra 1 , Marta Truffi 1 , Maria A. Rizzuto 2 , Luca Sorrentino 1 , Erika Longhi 1 , Manuela Nebuloni 1 , Davide Prosperi 2 , Fabio Corsi 1, 3 1 Department of Biomedical and Clinical Sciences “
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1572c2f440178423bf2037cce75bfd
https://doi.org/10.18632/oncotarget.14204
https://doi.org/10.18632/oncotarget.14204